Fumaz Carmina R, Ayestaran Aintzane, Perez-Alvarez Nuria, Muñoz-Moreno Jose A, Ferrer Maria Jose, Negredo Eugenia, Clotet Bonaventura
1 HIV Unit- Lluita contra la Sida Foundation- Germans Trias i Pujol University Hospital- Universitat Autònoma de Barcelona, Barcelona, Spain.
2 Lluita contra la Sida Foundation- Universitat Politècnica de Catalunya, Barcelona, Spain.
Am J Mens Health. 2017 May;11(3):647-653. doi: 10.1177/1557988316669041. Epub 2016 Sep 19.
The prevalence and associated factors of erectile dysfunction (ED) in Human Immunodeficiency Virus (HIV)-infected men remain controversial. The authors evaluated ED, clinical, and emotional variables in a group of 501 HIV-infected men in a cross-sectional 4-month observational study. ED was assessed using the International Index of Erectile Function-5 and emotional status using the Hospital Anxiety and Depression (HAD) questionnaire. Median age (interquartile range) was 42 (35, 48) years. Time since HIV diagnosis was 6.3 (2.6, 17.1) years, 92% were taking antiretroviral treatment and 81.8% had an HIV-RNA viral load <50 copies. The prevalence of ED was 58.5%. ED was mild in 30.1%, mild to moderate in 19.5%, moderate in 6.1%, and severe in 2.5%. ED medications were used by 19% of men. In the univariate analysis, the variables associated with all degrees of ED were older age, longer time since HIV diagnosis, higher scores in HAD, not taking efavirenz, taking etravirine, taking ritonavir, HIV/Hepatitis C Virus coinfection, and taking a protease inhibitor-containing regimen. For mild to moderate, moderate, and severe ED, the same variables were significant, as were lower nadir CD4 cell count, lower social support, taking atazanavir, concomitant conditions, and concomitant treatments. The variables that remained significant in the multivariate analyses, considering all degrees of ED or excluding mild ED were the following: older age and higher scores in HAD total. In summary, ED affected more than half of this cohort of well controlled HIV-infected men. Age and emotional status seemed to play a fundamental role in its presence.
人类免疫缺陷病毒(HIV)感染男性勃起功能障碍(ED)的患病率及其相关因素仍存在争议。作者在一项为期4个月的横断面观察性研究中,对501名HIV感染男性的ED、临床和情绪变量进行了评估。使用国际勃起功能指数-5评估ED,使用医院焦虑抑郁量表(HAD)问卷评估情绪状态。中位年龄(四分位间距)为42(35,48)岁。自诊断HIV以来的时间为6.3(2.6,17.1)年,92%的患者正在接受抗逆转录病毒治疗,81.8%的患者HIV-RNA病毒载量<50拷贝。ED的患病率为58.5%。轻度ED占30.1%,轻度至中度ED占19.5%,中度ED占6.1%,重度ED占2.5%。19%的男性使用了ED药物。在单因素分析中,与所有程度ED相关的变量包括年龄较大(older age)、自HIV诊断以来时间较长、HAD得分较高、未服用依非韦伦、服用依曲韦林、服用利托那韦、HIV/丙型肝炎病毒合并感染以及采用含蛋白酶抑制剂的治疗方案。对于轻度至中度、中度和重度ED,相同的变量具有显著性,此外还有较低的最低CD4细胞计数、较低的社会支持、服用阿扎那韦、合并症以及合并治疗。在多因素分析中,考虑所有程度的ED或排除轻度ED后仍具有显著性的变量如下:年龄较大和HAD总分较高。总之,ED影响了这群病情得到良好控制的HIV感染男性中的一半以上。年龄和情绪状态似乎在ED的发生中起着重要作用。